US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

44.42

+1.092.52%

Volume:6K

Turnover:275.32K

Market Cap:5.55M

PE:- -

High:45.10

Open:43.74

Low:43.74

Close:43.33

52wk High:45.10

52wk Low:25.71

Shares:125.00K

Float Shares:125.00K

Volume Ratio:0.49

T/O Rate:4.91%

Dividend:0.62

Dividend Rate:1.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.

Regeneron Pharmaceuticals (REGN) Wins Pasatru Approval, Is The Upside Already Priced In?

Simply Wall St.

Funds: What a Top Biotech Fund is Buying Now

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Moderna Inc. Stock Advances 8.9%, Outperforms Peers

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims

CStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS5007

Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block

Simply Wall St.

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial

Regeneron’s Pasatru granted FDA approval for FOP

Wall Street Analysts Are Bullish on Top Healthcare Picks

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Sweden's Medivir Q2 Turnover Falls

Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray

Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TBXU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":44.4163,"timestamp":1787342400000,"preClose":43.3255,"halted":0,"volume":6138,"delay":0,"changeRate":0.025176858893723134,"floatShares":125000,"shares":125000,"eps":0,"marketStatus":"Pre-Mkt","change":1.0908,"latestTime":"08-24 04:03:08 EDT","open":43.74,"high":45.1,"low":43.74,"amount":275315,"amplitude":0.03139,"askPrice":69.31,"askSize":100,"bidPrice":19.53,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":44.4163,"sharesOutstanding":100001,"nav":44.376,"aum":5547067.57,"dividendRate":0.013999,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":44.37,"preClose":44.4163,"latestTime":"16:10 EDT","volume":6,"amount":266.4978,"timestamp":1787343004463,"change":-0.0463,"changeRate":-0.001042,"amplitude":0},"volumeRatio":0.48867870216547865},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":125000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.48867870216547865,"shares":125000,"dividePrice":0.6218,"high":45.1,"amplitude":0.03139,"preClose":43.3255,"low":43.74,"week52Low":25.71,"pbRate":"--","week52High":45.1,"institutionHeld":0,"latestPrice":44.4163,"eps":0,"divideRate":0.013999,"volume":6138,"delay":0,"ttmEps":0,"open":43.74,"prevYearClose":31.065,"prevWeekClose":37.6716,"prevMonthClose":34.3127,"prevQuarterClose":32.1223,"fiveDayClose":37.6716,"twentyDayClose":32.6163,"sixtyDayClose":28.9991},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661222504","title":"Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222504","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222504?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:00","pubTimestamp":1787554851,"startTime":"0","endTime":"0","summary":"Daiichi Sankyo names Ken Keller chief commercialization officer, effective April 2027Daiichi Sankyo named Ken Keller chief commercialization officer, effective April 1, 2027, to run a new globally int","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLbyMxfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0058720904.USD","LU2089984988.USD","LU2242646821.SGD","PJP","BK4533","IE00B2B36J28.USD","LU2112291526.USD","BK4585","IE00BFTCPJ56.SGD","PBE","LU0122379950.USD","LU1023059063.AUD","LU0109394709.USD","BBH","BK4599","LU0868494617.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU2242652126.USD","IE0009355771.USD","AMGN","LU0320765992.SGD","BIB","IE00B4R5TH58.HKD","SG9999001440.SGD","LU2468319806.SGD","BK4588","LU0889565916.HKD","BK4139","IBB","LU1057294990.SGD","LU1571399168.USD","LU1061106388.HKD","IBBQ","IE00BJT1NW94.SGD","BK4581","LU0289739699.SGD","LU1983299246.USD","BK4566","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661228075","title":"Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228075","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228075?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:29","pubTimestamp":1787542174,"startTime":"0","endTime":"0","summary":"Earlier in August 2026, VIAVI Solutions launched Vertex 6.0, an enhanced channel emulation platform with 400 MHz instantaneous bandwidth and support for carrier frequencies up to 23.6 GHz, targeting next-generation 6G and Wi‑Fi 7/8 testing and integrating real-world RF propagation into lab environments.\nThis upgrade, the first since acquiring Spirent’s high-speed Ethernet, network security and channel emulation testing business, positions Vertex 6.0 as a modular RF digital twin platform...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1674673428.USD","LU1585245621.USD","BK4023","LU0061475181.USD","GNMX","IDNA","LU2417539215.USD","VIAG","LU0234570918.USD","IBBQ","VERX","BBH","LU2362540622.SGD","TBXU","IE00B2B36J28.USD","LU2065171311.SGD","IBB","LU1093756325.SGD","LU2065171402.SGD","LU0417517546.SGD","LU2462157665.USD","LU0889565916.HKD","AGIX","BK4567","LU0432979614.USD","IE0002141913.USD","VTHR","BK4585","LU0240877869.USD","BK4588","LU1069344957.HKD","LU2065170008.USD","LU2236285917.USD","LU0109394709.USD","LU2089984988.USD","PBE","BK4532","SG9999001176.SGD","BIB","SG9999013999.USD","QTOC","LU0205194284.USD","VIAV","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","AIPO","ARTY","VRTX","CHAT","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661302215","title":"Regeneron Pharmaceuticals (REGN) Wins Pasatru Approval, Is The Upside Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661302215","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661302215?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362233,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) stock moved after the U.S. Food and Drug Administration approved Pasatru for adults with fibrodysplasia ossificans progressiva. This new rare disease therapy is supported by late stage OPTIMA trial data.\nSee our latest analysis for Regeneron Pharmaceuticals.\nThe Pasatru approval comes after a strong run in Regeneron Pharmaceuticals’ stock, with a 30.55% 90 day share price return and a 42.21% 1 year total shareholder return, suggesting recent momentum after...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regeneron-pharmaceuticals-regn-wins-pasatru-approval-is-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regeneron-pharmaceuticals-regn-wins-pasatru-approval-is-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0109394709.USD","TBXU","BK4139","LU0823434740.USD","LU0823434583.USD","LU2089984988.USD","LU0823416689.USD","IBBQ","REGN","LU0289739699.SGD","LU0889565916.HKD","LU0053666078.USD","LU2237438978.USD","LU2362541273.HKD","DCF","BBH","LU2023250504.SGD","LU2106854487.HKD","IBB","LU0114720955.EUR","LU2362541513.USD","LU0882574055.USD","LU1917777945.USD","LU0058720904.USD","LU0320765992.SGD","BK4585","LU2468319806.SGD","LU2362540622.SGD","BK4588","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069344957.HKD","IE00B7SZLL34.SGD","IE00B19Z9Z06.USD","LU0965509010.AUD","LU0061475181.USD","BK4533","LU1585245621.USD","LU1093756325.SGD","BK4550","LU1974910355.USD","IE00BN0W2T93.GBP","MEDI","IBB","LU2242646821.SGD","LU2417539215.USD","LU2106854487.HKD","BK4583","REGN","BK4566","BK4585","SG9999015986.USD","LU2362540622.SGD","LU1917777945.USD","SG9999001176.USD","BK4568","IE00B19Z3581.USD","LU2324357040.USD","SG9999013999.USD","LU0432979614.USD","LU0154245756.USD","LU1778281490.HKD","LU1023059063.AUD","LU1037948897.HKD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","LU0823434583.USD","IE00B3T34201.USD","BK4532","LU2462157665.USD","LU1061106388.HKD","LU2087621335.USD","PBE","BK4567","BK4588","PJP","LU1934455277.USD","IE0009355771.USD","IE00B19Z9P08.USD","LU0882574055.USD","04332","LU1037948541.HKD","SGXZ57979304.SGD","IDNA","LU2362541513.USD","BIB","LU2357627491.SGD","LU0256863811.USD","LU1035775433.USD","IE00BN0W2V16.EUR","LU1430594728.SGD","LU0889565916.HKD","LU2236285917.USD","LU2242652126.USD","GNMX","LU0320765992.SGD","BK4007","LU0965509283.SGD","IBBQ","LU0823416689.USD","LU1934455194.USD","IE00B894F039.SGD","LU1057294990.SGD","IE00BJJMRZ35.SGD","LU0859254822.USD","BBH","LU1066051498.USD","IE00BSNM7G36.USD","LU0417517546.SGD","IE00BN0W2W23.USD","LU2456880835.USD","SG9999001176.SGD","LU1934455863.HKD","BK4139","LU1571399168.USD","VRTX","SG9999015945.SGD","LU2237438978.USD","IE0002141913.USD","LU0868494617.USD","LU0234570918.USD","LU0965509101.SGD","LU0122379950.USD","SG9999001440.SGD","LU1839511570.USD","BMED","BK4599","IE0002270589.USD","LU0114720955.EUR","TBXU","IE00BJT1NW94.SGD","SG9999015952.SGD","LU1983299246.USD","LU2089984988.USD","BK4534","LU2112291526.USD","LU0058720904.USD","XBI","LU1674673428.USD","BK4581","IE00B2B36J28.USD","LU0109394709.USD","BK4578","AMGN","LU1093756168.USD","GILD","LU0053666078.USD","LU2362541273.HKD","LU1674673691.USD","IE00BZ9MQY76.HKD","JAZZ","LU0823434740.USD","LU0154245673.USD","LU2468319806.SGD","LU0289739699.SGD","LU0079474960.USD","TMED","IE00BKVL7J92.USD","LU0965508806.USD","LU2023250504.SGD","SG9999015978.USD","LU0861579265.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661187372","title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","url":"https://stock-news.laohu8.com/highlight/detail?id=2661187372","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661187372?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:22","pubTimestamp":1787354576,"startTime":"0","endTime":"0","summary":"Gilead director Jeffrey Bluestone disposes of 5,000 common shares worth $727,333.60Gilead director Jeffrey Bluestone exercised stock options on Aug. 20, 2026, acquiring 5,000 shares at USD 61.35 to US","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4cgVd7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU0859254822.USD","GILD","BIB","IE00BSNM7G36.USD","LU1674673428.USD","BK4583","LU1934455863.HKD","IE00B19Z3B42.SGD","IBBQ","MEDI","BK4588","SG9999015978.USD","LU0320765992.SGD","LU0861579265.USD","LU0965508806.USD","LU1066053197.SGD","LU0882574055.USD","LU0965509101.SGD","LU1057294990.SGD","LU1430594728.SGD","BK4566","IE00B3T34201.USD","SG9999015952.SGD","LU0289739699.SGD","LU2357627491.SGD","SG9999015945.SGD","LU0234570918.USD","LU2089984988.USD","LU0965509010.AUD","LU0058720904.USD","BK4139","LU1674673691.USD","IE00B19Z3581.USD","BK4568","BK4532","LU1571399168.USD","LU1585245621.USD","LU2468319806.SGD","BBH","LU0965509283.SGD","IBB","LU2087621335.USD","LU0122379950.USD","BMED","TMED","TBXU","LU1778281490.HKD","SG9999015986.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661972042","title":"Moderna Inc. Stock Advances 8.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661972042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661972042?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:33","pubTimestamp":1787344380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 8.9% to $145.13 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.Moderna Inc. closed 17.8% below its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.24, Pfizer Inc. rose 1.0% to $28.07, and Gilead Sciences Inc. rose 1.87% to $146.12.Trading volume totaled 86.7 million, compared to the 50-day average of 13.0 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","GILD","LU1066053197.SGD","BIB","SG9999015952.SGD","BK4551","SG9999015986.USD","LU1037948541.HKD","IDNA","WDNA","MRNX","LU0965509010.AUD","MEDI","IBB","LU0965508806.USD","SG9999015978.USD","LU2357627491.SGD","LU0058720904.USD","LU0823416689.USD","LU1430594728.SGD","LGHT","BK4501","LU2324357040.USD","BK4550","MRNA","LU1585245621.USD","TMED","LU1571399168.USD","BMED","LU1674673691.USD","LU1057294990.SGD","BK4583","LU0234570918.USD","BBH","GNOM","LU0861579265.USD","LU1061106388.HKD","BK4585","LU2112291526.USD","LU1934455194.USD","MRNY","LU0965509283.SGD","LU0289739699.SGD","LU0122379950.USD","IE0002270589.USD","LU1934455863.HKD","TBXU","LU1839511570.USD","BK4532","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661940352","title":"Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2661940352","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661940352?lang=en_us&edition=fundamental","pubTime":"2026-08-22 01:58","pubTimestamp":1787335117,"startTime":"0","endTime":"0","summary":"Gilead declares Q3 2026 dividend of R$ 0.24 per unitGilead Sciences set a Q3 2026 distribution of R$ 0.24 per unit for BRGILDBDR 000.Last day to trade with rights: Sept. 11, 2026.Payment date: Oct. 5,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL12Yy9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU0965508806.USD","LU0965509283.SGD","SG9999015952.SGD","BK4550","BK4585","LU2112291526.USD","LU1037948897.HKD","LU2357627491.SGD","TMED","IE00B3T34201.USD","BMED","BIB","LU1585245621.USD","LU0859254822.USD","BK4568","GILD","IE00B7SZLL34.SGD","IBBQ","LU1037948541.HKD","LU1674673691.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","TBXU","BBH","LU2089984988.USD","LU1061106388.HKD","LU1430594728.SGD","IE00BKVL7J92.USD","LU1066053197.SGD","LU0823416689.USD","BK4583","LU0965509010.AUD","IE0002270589.USD","BK4588","LU0882574055.USD","LU0889565916.HKD","LU2324357040.USD","LU1674673428.USD","LU1023059063.AUD","BK4139","IE00BSNM7G36.USD","LU0122379950.USD","SG9999015986.USD","LU0114720955.EUR","BK4532","LU2468319806.SGD","BK4578","LU0965509101.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661887294","title":"Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661887294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661887294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:34","pubTimestamp":1787330049,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s new Phase 3 DeLLphi-315 study tests its cancer drug tarlatamab in pe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","LU0109394709.USD","TBXU","IE0009355771.USD","BK4139","LU2089984988.USD","IE00BJT1NW94.SGD","PBE","LU2242646821.SGD","IBBQ","LU0868494617.USD","LU1057294990.SGD","LU0289739699.SGD","LU0889565916.HKD","BIB","BK4599","IE0002141913.USD","BK4566","IE00B4R5TH58.HKD","BK4581","LU2242652126.USD","LU2112291526.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU0122379950.USD","BK4534","PJP","IE00BFTCPJ56.SGD","BK4533","BBH","AMGN","IE00BJJMRZ35.SGD","IBB","LU1571399168.USD","LU0058720904.USD","SG9999001440.SGD","LU0320765992.SGD","LU1983299246.USD","BK4585","LU2468319806.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260437","title":"Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260437?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:58","pubTimestamp":1787313533,"startTime":"0","endTime":"0","summary":"A class action lawsuit was filed against biotechnology company Regeneron ($REGN) on July 16, which could put further pressure on its troubled share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","BBP","LNGR","LU2023250504.SGD","TBXU","LU0289739699.SGD","FHLC","BK4585","LU0889565916.HKD","LU2362540622.SGD","LU2362541273.HKD","RSPH","LU0320765992.SGD","IEIH","LU2106854487.HKD","AGNG","BK4139","BK4588","LU0823434740.USD","SYNB","LU0058720904.USD","LU0114720955.EUR","LU2362541513.USD","LU1974910355.USD","REGN","LU0053666078.USD","LU0109394709.USD","LU0823416689.USD","LU2468319806.SGD","LU2237438978.USD","BBH","LU0823434583.USD","LU2089984988.USD","LU0882574055.USD","LU1917777945.USD","IBB","JDOC","XT","FWD","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661302932","title":"CStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS5007","url":"https://stock-news.laohu8.com/highlight/detail?id=2661302932","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661302932?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:07","pubTimestamp":1787263635,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals ( ($HK:2616) ) just unveiled an announcement. CStone Pharmaceuticals has secured rapid investigational new drug approval in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cstone-gains-rapid-china-ind-approval-for-egfr-her3-adc-cs5007?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cstone-gains-rapid-china-ind-approval-for-egfr-her3-adc-cs5007?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","TBXU","NETL","IND","BK4080","ADC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661923014","title":"Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block","url":"https://stock-news.laohu8.com/highlight/detail?id=2661923014","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661923014?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258134,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong long term returns over the past five years, yet current valuation checks and market multiples still point to the shares screening as undervalued. With recent news flow focused on its HIV and oncology franchises and on legal protection of its U.S. drug pricing, investors are weighing how much of this is already reflected in the price.\n\nGilead Sciences has returned 148.1% over the past five years, which puts recent valuation questions in the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BIB","IBBQ","IE00BSNM7G36.USD","LU1934455863.HKD","IE0002270589.USD","TACU","LU2112291526.USD","TBXU","BK4566","LU1934455194.USD","LU0823416689.USD","LU2087621335.USD","LU0965508806.USD","LU0109394709.USD","IE00B19Z3581.USD","LU0889565916.HKD","LU0965509283.SGD","IE00BKVL7J92.USD","LU0965509010.AUD","SG9999015945.SGD","TSPA","GILD","LU0861579265.USD","SG9999015986.USD","BBH","MEDI","IE00B19Z3B42.SGD","BK4585","BK4550","CDIG","LU1057294990.SGD","LU0289739699.SGD","LU0320765992.SGD","LU1066051498.USD","LU2468319806.SGD","LU0114720955.EUR","IE00BZ1G4Q59.USD","LU0122379950.USD","BMED","LU1037948541.HKD","IBB","BK4588","LU1037948897.HKD","LU1934455277.USD","DAPP","LU1430594728.SGD","LU1778281490.HKD","SG9999015978.USD","LU2089984988.USD","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232279","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232279","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232279?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 2.82% to $143.44 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.The stock's fall snapped a seven-day winning streak.Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.21% to $267.37, Pfizer Inc.  fell 1.59% to $27.79, and Abbott Laboratories  fell 0.25% to $114.14.Trading volume  remained 286,153 below its 50-day average volume of 7.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU0965509283.SGD","LU1778281490.HKD","BK4585","BBH","IE0002270589.USD","IE00B19Z3581.USD","LU1037948897.HKD","LU1066053197.SGD","LU1934455277.USD","LU0861579265.USD","LU1023059063.AUD","LU1674673428.USD","BMED","IBBQ","LU0109394709.USD","BK4568","IE00B19Z3B42.SGD","LU1057294990.SGD","LU2468319806.SGD","LU1585245621.USD","LU1839511570.USD","LU1934455863.HKD","IE00B3T34201.USD","LU0889565916.HKD","LU1674673691.USD","BK4550","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","SG9999015945.SGD","LU0114720955.EUR","LU1430594728.SGD","LU2087621335.USD","BK4588","BK4566","LU0823416689.USD","SG9999015986.USD","LU1037948541.HKD","IE00BSNM7G36.USD","SG9999015978.USD","BK4532","BK4583","LU0058720904.USD","TBXU","GILD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU2112291526.USD","LU0289739699.SGD","LU0965509101.SGD","IBB","LU1571399168.USD","LU0320765992.SGD","LU0882574055.USD","LU0965508806.USD","BIB","MEDI","LU2324357040.USD","LU0234570918.USD","LU1934455194.USD","LU0965509010.AUD","LU1066051498.USD","TMED","BK4578","BK4139","LU1061106388.HKD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232427","title":"Moderna Inc. Stock Slips 23.5%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232427?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:33","pubTimestamp":1787257980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. cratered 23.5% to $133.32 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,067.17 and Dow Jones Industrial Average falling 1.3% to 52,759.21.Moderna Inc. closed 24.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 2.2% to $267.37, Pfizer Inc. fell 1.6% to $27.79, and Gilead Sciences Inc. fell 2.82% to $143.44.Trading volume totaled 97.3 million, compared to the 50-day average of 11.2 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","IE00BSNM7G36.USD","BK4566","LU2468319806.SGD","LU1778281490.HKD","BK4551","BK4532","IE00B3T34201.USD","TBXU","MRNX","SG9999015952.SGD","LU0823416689.USD","LU0058720904.USD","LU1839511570.USD","WDNA","GILD","LU2324357040.USD","LU1934455194.USD","TMED","BIB","BMED","IE00B7SZLL34.SGD","LU1430594728.SGD","LU0882574055.USD","BBH","SG9999015945.SGD","GNOM","IBBQ","BK4533","IE00B19Z3B42.SGD","BK4578","MRNA","LU1674673691.USD","LGHT","LU1037948541.HKD","LU0114720955.EUR","MEDI","LU1585245621.USD","LU0289739699.SGD","LU1674673428.USD","LU0109394709.USD","LU0965509010.AUD","BK4139","BK4550","IBB","IDNA","BK4548","LU1023059063.AUD","LU2112291526.USD","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661323699","title":"Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661323699","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661323699?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243431,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. The Phase 2b study A Phase 2b, Open-label Study to Evaluat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","BK4585","LU2468319806.SGD","SG9999001176.USD","IE00B2B36J28.USD","LU0079474960.USD","GNMX","TBXU","SGXZ57979304.SGD","LU2362541273.HKD","LU2324357040.USD","LU1815336091.USD","LU2417539215.USD","LU0757428866.USD","IE00B894F039.SGD","BIB","IE00B19Z3581.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2237438978.USD","LU0432979614.USD","BBH","LU0256863811.USD","PBE","SG9999013999.USD","LU2362540622.SGD","LU2362541513.USD","LU1093756168.USD","BK4567","IBBQ","LU1069344957.HKD","IE0009355771.USD","LU2089984988.USD","IE00B19Z3B42.SGD","BK4588","LU1093756325.SGD","LU1674673691.USD","IE00B19Z9P08.USD","LU0289739699.SGD","LU0566484027.USD","LU1674673428.USD","SG9999001176.SGD","VERX","VRTX","BK4139","IBB","IDNA","IE00BFTCPJ56.SGD","LU2456880835.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287604","title":"Regeneron’s Pasatru granted FDA approval for FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287604","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287604?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:20","pubTimestamp":1787232025,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has approved Pasatru to reduce new heterotopic ossification and reduce clinician-assessed disease flare-ups i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","GNMX","TBXU","IEIH","IBB","MRNY","NVIB","XLVX","BK4588","LABU","GDOC","MEDI","LFSC","FRTY","IYH","RSPH","BK4585","TECB","MRNX","BBP","SYNB","IDNA","PINK","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660728971","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660728971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660728971?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:40","pubTimestamp":1787226007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Glaukos (GKOS) and Ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0079474960.USD","LU0109394709.USD","LU2324357040.USD","LU0432979614.USD","IE00BZ9MQY76.HKD","LU2065731478.USD","IE0009354923.USD","IBB","LU2462157665.USD","LU1674673428.USD","LU2362541273.HKD","IE00B4R5TH58.HKD","LU0289739699.SGD","IDNA","BK4567","LU0234570918.USD","BIB","LU2236285917.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2362541513.USD","BK4533","SG9999013999.USD","IBBQ","SGXZ57979304.SGD","IE00BJT1NW94.SGD","BBH","LU1430594728.SGD","LU1093756168.USD","LU2362540622.SGD","LU1585245621.USD","TBXU","LU2456880835.USD","LU1778281490.HKD","LU0061475181.USD","BK4139","LU1035775433.USD","BK4585","LU2468319806.SGD","GKOS","LU1069344957.HKD","LU0889565916.HKD","SG9999001176.SGD","LU1878469433.USD","LU0417517546.SGD","GNMX","BK4082","IE00B19Z9P08.USD","LU2237438978.USD","LU2417539215.USD","PBE","LU0823416689.USD","BK4588","LU1093756325.SGD","VRTX","BK4532","IE00B2B36J28.USD","LU0058720904.USD","LU1674673691.USD","LU0256863811.USD","IE00B19Z9Z06.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B19Z3581.USD","IE0009355771.USD","IE00B19Z3B42.SGD","BK4548","IE00B894F039.SGD","SG9999001176.USD","LU2089984988.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402506","title":"Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402506?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:31","pubTimestamp":1787214660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. surged 13% to 5.39 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 25698.49.The stock's rise snapped a two-day losing streak.Sino Biopharmaceutical Ltd. closed 41% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 9.6% and Amgen Inc. remained unchanged.Trading volume totaled 382.5 million shares, compared to the 50-day average of 95.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK4534","IE00BZ08YS42.EUR","BK1589","IE00B2B36J28.USD","AMGN","IE0002141913.USD","LU2112291526.USD","LU1023059063.AUD","IBBQ","LU1571399168.USD","PJP","BBH","TBXU","BIB","BK4588","IE00BZ08YT58.USD","BK1191","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2242646821.SGD","HK0000165453.HKD","BK1521","01177","IE00B4R5TH58.HKD","IBB","LU0058720904.USD","LU0122379950.USD","LU0289739699.SGD","LU2468319806.SGD","BK4599","LU1983299246.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0889565916.HKD","BK4139","IE00BZ08YR35.GBP","LU1057294990.SGD","LU0109394709.USD","LU0320765992.SGD","LU1061106388.HKD","PBE","LU0868494617.USD","BK4533","BK4581","SG9999001440.SGD","LU2089984988.USD","BK4566","BK4585","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660340609","title":"Sweden's Medivir Q2 Turnover Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2660340609","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660340609?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:41","pubTimestamp":1787208103,"startTime":"0","endTime":"0","summary":"Sweden's Medivir Q2 turnover fallsOverviewSweden drug developer's Q2 net turnover declined yr/yr, EBITDA loss narrowedCompany completed SEK 140 mln share issue to fund rare bone disease drug developme","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H07I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU2272731782.SGD","LU2362541513.USD","LU0320765489.SGD","LU0109394709.USD","LU2362541273.HKD","LU1917777945.USD","LU1992135472.HKD","LU2357305700.SGD","LU2362540622.SGD","BK4585","IBBQ","BK4588","LU2473716301.USD","LU1303367103.USD","LU1720051017.SGD","LU2322448957.HKD","LU0289960550.SGD","LU1974910355.USD","LU2106854487.HKD","LU0889565916.HKD","LU2237438978.USD","LU1366192091.USD","FLEX","LU0289739343.SGD","LU0289739699.SGD","LU0823434740.USD","LU2089984988.USD","REGN","LU2322448791.USD","LU0058720904.USD","LU0823434583.USD","BK4139","LU0208291251.USD","LU2468319806.SGD","BBH","LU2023250504.SGD","LU0963586101.USD","IBB","LU0511384066.AUD","LU2272731600.USD","LU0057025933.USD","LU2272731865.HKD","LU0069063385.USD","TBXU","BK4512","FLEL","LU0114720955.EUR","LU0053666078.USD","LU1720051108.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660028408","title":"Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2660028408","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660028408?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:43","pubTimestamp":1787200984,"startTime":"0","endTime":"0","summary":"Glenmark Pharmaceuticals Limited ( ($IN:GLENMARK) ) just unveiled an announcement. Glenmark Pharmaceuticals has secured U.S. FDA approval for its F...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","TBXU","XLVX","IEIH","IBB","LFSC","MRNY","IYH","FRTY","IDNA","BK4585","GDOC","PINK","BK4588","RSPH","SYNB","TECB","PSCH","BMED","MEDI","BBP","MRNX","LABU","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479477","title":"Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479477","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479477?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:37","pubTimestamp":1787182673,"startTime":"0","endTime":"0","summary":"Vertex Resource Group Ltd. ( ($TSE:VTX) ) has issued an update. Vertex Resource Group Ltd. reported stronger second-quarter 2026 results, highlight...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","BIB","BK4533","SG9999001176.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2236285917.USD","SG9999013999.USD","LU0256863811.USD","LU0058720904.USD","VERX","IE00B4R5TH58.HKD","LU0234570918.USD","SG9999001176.SGD","IE00BFTCPJ56.SGD","LU1093756168.USD","LU2237438978.USD","IE0002141913.USD","LU1093756325.SGD","SGXZ57979304.SGD","LU2468319806.SGD","LU1815336091.USD","TBXU","LU1778281490.HKD","LU2456880835.USD","LU0889565916.HKD","IE00B19Z9P08.USD","IDNA","LU2462157665.USD","PBE","GNMX","LU0289739699.SGD","BK4532","IBBQ","IBB","LU0320765992.SGD","BK4023","VRTX","IE00B19Z9Z06.USD","IE0002270589.USD","IE00BZ9MQY76.HKD","LU0566484027.USD","LU0061475181.USD","LU1035775433.USD","IE00B19Z3581.USD","BK4585","BBH","BK4588","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}